NO20054514L - Taksanderivater - Google Patents

Taksanderivater

Info

Publication number
NO20054514L
NO20054514L NO20054514A NO20054514A NO20054514L NO 20054514 L NO20054514 L NO 20054514L NO 20054514 A NO20054514 A NO 20054514A NO 20054514 A NO20054514 A NO 20054514A NO 20054514 L NO20054514 L NO 20054514L
Authority
NO
Norway
Prior art keywords
acyloxy
hydrogen
keto
hydroxy
carbonate
Prior art date
Application number
NO20054514A
Other languages
English (en)
Inventor
Robert A Holton
Zhuming Zhang
Paul A Clark
Original Assignee
Univ Florida State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27368950&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20054514(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Publication of NO20054514L publication Critical patent/NO20054514L/no
Application filed by Univ Florida State filed Critical Univ Florida State

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • C07F7/1872—Preparation; Treatments not provided for in C07F7/20
    • C07F7/1892—Preparation; Treatments not provided for in C07F7/20 by reactions not provided for in C07F7/1876 - C07F7/1888

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epoxy Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Fats And Perfumes (AREA)
  • Percussion Or Vibration Massage (AREA)
  • Soil Working Implements (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)

Abstract

Taksan med formelen: hvor M er et metall eller omfatter ammonium; R1 er hydrogen, hydroksy, beskyttet hydroksy eller danner sammen med R14 eller R2 et karbonat; R2 er keto, -OT2, acyloksy eller danner sammen med R1 et karbonat; R4 er -OT4 eller acyloksy; R7 er -OSiRJRKRL; R9 er hydrogen, keto, -OT9 eller acyloksy; R10 er hydrogen, keto, -OT10 eller acyloksy; R13 er hydroksy, beskyttet hydroksy, keto eller MO-; R14 er hydrogen, -OT14, acyloksy eller danner sammen med R1 et karbonat; RJ, RK, RL er uavhengig av hverandre hydrokarbyl, substituert hydrokarbyl eller heteroaryl, forutsatt imidlertid at dersom hver av RJ, RK og RL er alkyl, omfatter minst én av RJ, RK og RL et karbonskjelett med minst fire karbonatomer; og T2, T4, T9, T10 og T14 uavhengig av hverandre er hydrogen eller en hydroksybeskyttelsesgruppe.
NO20054514A 1997-08-18 2005-09-29 Taksanderivater NO20054514L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US5600097P 1997-08-18 1997-08-18
US8126598P 1998-04-09 1998-04-09
US09/063,477 US7288665B1 (en) 1997-08-18 1998-04-20 Process for selective derivatization of taxanes
PCT/US1998/017016 WO1999009021A1 (en) 1997-08-18 1998-08-17 Process for selective derivatization of taxanes

Publications (1)

Publication Number Publication Date
NO20054514L true NO20054514L (no) 1999-06-18

Family

ID=27368950

Family Applications (4)

Application Number Title Priority Date Filing Date
NO19991838A NO325139B1 (no) 1997-08-18 1999-04-16 Fremgangsmate for acylering av en C(10)-hydroksygruppe i et taksan som har C(7)- og C(10)-hydroksygrupper
NO20054512A NO20054512L (no) 1997-08-18 2005-09-29 Taksanderivater
NO20054514A NO20054514L (no) 1997-08-18 2005-09-29 Taksanderivater
NO20054513A NO20054513L (no) 1997-08-18 2005-09-29 Taksanderivater

Family Applications Before (2)

Application Number Title Priority Date Filing Date
NO19991838A NO325139B1 (no) 1997-08-18 1999-04-16 Fremgangsmate for acylering av en C(10)-hydroksygruppe i et taksan som har C(7)- og C(10)-hydroksygrupper
NO20054512A NO20054512L (no) 1997-08-18 2005-09-29 Taksanderivater

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO20054513A NO20054513L (no) 1997-08-18 2005-09-29 Taksanderivater

Country Status (25)

Country Link
US (5) US7288665B1 (no)
EP (6) EP1193262A1 (no)
JP (1) JP2001504864A (no)
KR (1) KR100596989B1 (no)
CN (3) CN100351246C (no)
AT (3) ATE341540T1 (no)
AU (1) AU744987B2 (no)
BR (1) BR9806145A (no)
CA (2) CA2597799A1 (no)
CY (1) CY1105399T1 (no)
CZ (1) CZ296580B6 (no)
DE (3) DE69834584T2 (no)
DK (3) DK0956284T3 (no)
ES (3) ES2259646T3 (no)
HU (1) HUP0300425A3 (no)
ID (1) ID21654A (no)
IL (3) IL129386A0 (no)
NO (4) NO325139B1 (no)
NZ (1) NZ335156A (no)
PL (3) PL193674B1 (no)
PT (3) PT1170293E (no)
RU (1) RU2225402C2 (no)
SG (1) SG97986A1 (no)
WO (1) WO1999009021A1 (no)
ZA (1) ZA987394B (no)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5750736A (en) * 1996-07-11 1998-05-12 Napro Biotherapeutics, Inc. Method for acylating 10-deacetylbaccatin III selectively at the c-10 position
US7288665B1 (en) 1997-08-18 2007-10-30 Florida State University Process for selective derivatization of taxanes
IT1308636B1 (it) * 1999-03-02 2002-01-09 Indena Spa Procedimento per la preparazione di tassani da 10-desacetilbaccatinaiii.
CO5280224A1 (es) 2000-02-02 2003-05-30 Univ Florida State Res Found Taxanos sustituidos con ester en c7, utiles como agentes antitumorales y composiciones farmaceuticas que los contienen
DE60133600T2 (de) 2000-02-02 2009-06-10 Florida State University Research Foundation, Inc., Tallahassee C7-carbamoyloxysubstituierte taxane als antitumormittel
RU2264400C2 (ru) 2000-02-02 2005-11-20 Флорида Стейт Юниверсити Рисерч Фаундейшн, Инк. Таксан, фармацевтическая композиция на его основе и способ ингибирования роста опухоли
KR20010112393A (ko) 2000-02-02 2001-12-20 플로리다 스테이트 유니버시티 리서치 파운데이션, 인크 항종양제로서 ｃ７ 헤테로치환된 아세테이트 탁산
JP2003522170A (ja) 2000-02-02 2003-07-22 フロリダ・ステイト・ユニバーシティ・リサーチ・ファウンデイション・インコーポレイテッド 抗腫瘍剤としてのｃ７カーボネート置換タキサン
US6664275B2 (en) 2000-02-02 2003-12-16 Fsu Research Foundation, Inc. C10 heterosubstituted acetate taxanes
HUP0200721A3 (en) 2000-02-02 2005-02-28 Univ Florida State Res Found C10 carbamoyloxy substituted taxanes as antitumor agents and pharmaceutical compositions containing them and their use
US6649632B2 (en) 2000-02-02 2003-11-18 Fsu Research Foundation, Inc. C10 ester substituted taxanes
US6362217B2 (en) * 2000-03-17 2002-03-26 Bristol-Myers Squibb Company Taxane anticancer agents
IT1320107B1 (it) * 2000-11-28 2003-11-18 Indena Spa Procedimento per la preparazione di derivati tassanici.
IT1319682B1 (it) * 2000-12-06 2003-10-23 Indena Spa Procedimento di sintesi del paclitaxel.
US7351542B2 (en) 2002-05-20 2008-04-01 The Regents Of The University Of California Methods of modulating tubulin deacetylase activity
EP2108362B1 (en) 2002-06-26 2013-05-29 MediGene AG A cationic liposomal preparation comprising a taxane
US20070172446A1 (en) 2003-05-16 2007-07-26 Intermune, Inc. Synthetic chemokine receptor ligands and methods of use thereof
CN1303077C (zh) * 2004-01-16 2007-03-07 桂林晖昂生化药业有限责任公司 合成紫杉烷的制备工艺
SV2006002010A (es) 2004-02-13 2006-08-23 Univ Florida State Res Found Taxanos sustituidos con esteres de ciclopentilo en c10
WO2005087222A1 (en) 2004-03-05 2005-09-22 Florida State University Research Foundation, Inc. C7 lactyloxy-substituted taxanes
MXPA06012606A (es) * 2004-05-14 2007-01-31 Immunogen Inc Un metodo facil para sintetizar compuestos de bacatina iii.
WO2006089209A2 (en) 2005-02-17 2006-08-24 The Board Of Trustees Of The Leland Stanford Junior University Txr1 and enhanced taxane sensitivity based on the modulation of a pathway mediated thereby
KR20080030013A (ko) * 2005-06-10 2008-04-03 플로리다 스테이트 유니버시티 리서치 파운데이션, 인크 폴리시클릭 융합 고리 화합물의 제조 방법
EP1893594A2 (en) * 2005-06-10 2008-03-05 Florida State University Research Foundation, Inc. Processes for the preparation of paclitaxel
MX2008011978A (es) 2006-03-22 2009-04-22 Medigene Ag Tratamiento del cancer de seno negativo al triple receptor.
US7847111B2 (en) * 2006-06-19 2010-12-07 Canada Inc. Semi-synthetic route for the preparation of paclitaxel, docetaxel, and 10-deacetylbaccatin III from 9-dihydro-13-acetylbaccatin III
PL210984B1 (pl) * 2006-10-31 2012-03-30 Inst Farmaceutyczny Sposób wytwarzania docetakselu
WO2008106491A2 (en) * 2007-02-27 2008-09-04 University Of Utah Research Foundation Peptides that interact with topoisomerase i and methods thereof
JP4833126B2 (ja) * 2007-03-26 2011-12-07 Ｎｔｎ株式会社 潤滑剤劣化検出装置および検出装置付き軸受
CN101274923B (zh) * 2007-03-27 2011-02-02 中国科学院大连化学物理研究所 一种制备紫杉醇，巴卡亭ⅲ及其衍生物的方法
CN101274924B (zh) * 2007-03-27 2010-11-10 中国科学院大连化学物理研究所 一种制备紫杉醇及其衍生物的方法
WO2009040829A1 (en) * 2007-09-27 2009-04-02 Benzochem Lifescience (P) Limited A novel process for the preparation of docetaxel
EP2276755A4 (en) 2008-03-31 2011-05-04 Univ Florida State Res Found C (10) -ETHYESTER- AND C (10) -CYCLOPROPYLESTER-SUBSTITUTED TAXANES
WO2009143454A2 (en) 2008-05-22 2009-11-26 Kereos, Inc. Combination antitumor therapy
US20110172293A1 (en) 2008-07-08 2011-07-14 Fish Jason E Methods and Compositions for Modulating Angiogenesis
CN101863861A (zh) * 2009-04-16 2010-10-20 山东靶点药物研究有限公司 一种简便高效地制备紫杉醇类似物Larotaxel的方法
US8791279B2 (en) * 2010-12-13 2014-07-29 Yung Shin Pharm. Ind. Co., Ltd. Process for preparing taxoids from baccatin derivatives using lewis acid catalyst
WO2012131698A1 (en) 2011-04-01 2012-10-04 Shilpa Medicare Limited Process for preparing docetaxel and its hydrate
US20130090484A1 (en) * 2011-10-11 2013-04-11 Scinopharm Taiwan Ltd. Process for making an intermediate of cabazitaxel
CN103159704B (zh) * 2011-12-12 2015-06-10 上海佰霖国际贸易有限公司 卡巴他赛中间体及卡巴他赛中间体的制备方法
IN2015DN00552A (no) 2012-07-19 2015-06-26 Redwood Bioscience Inc
JP2016500058A (ja) 2012-11-12 2016-01-07 レッドウッド バイオサイエンス， インコーポレイテッド 化合物および抱合体を生成するための方法
KR20230022452A (ko) 2013-02-15 2023-02-15 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 키메라 항원 수용체 및 이의 이용 방법
US9670162B2 (en) 2013-03-14 2017-06-06 The Board Of Trustees Of The Leland Stanford Junio Mitochondrial aldehyde dehyrogenase-2 modulators and methods of use thereof
CN103145654A (zh) * 2013-04-12 2013-06-12 江苏斯威森生物医药工程研究中心有限公司 一种多西他赛的半合成方法
WO2014191989A1 (en) * 2013-05-26 2014-12-04 Idd Therapeutics Ltd. Conjugate of a taxane and biotin and uses thereof
CA3178867A1 (en) 2013-11-27 2015-06-04 Redwood Bioscience, Inc. Hydrazinyl-pyrrolo compounds and methods for producing a conjugate
JP6615769B2 (ja) 2014-02-19 2019-12-04 アルデア ファーマシューティカルズ インコーポレイテッド ミトコンドリアアルデヒドデヒドロゲナーゼ２（ａｌｄｈ２）に結合する多環式アミド
TWI684600B (zh) 2014-03-21 2020-02-11 美商艾伯維有限公司 抗－ｅｇｆｒ抗體及抗體藥物結合物
EP3373977A4 (en) 2015-11-12 2019-07-17 The Board of Trustees of the Leland Stanford Junior University CELLULAR PENETRATION-RICH GUANIDINIC OLIGOPHOSPHOTRIESTERS FOR THE DELIVERY OF MEDICATION AND PROBE
TWI760319B (zh) 2015-12-30 2022-04-11 杏國新藥股份有限公司 乳癌治療
EP3231421A1 (en) 2016-04-11 2017-10-18 Greenaltech, S.L. Uses of a carotenoid in the treatment or prevention of stress induced conditions
US11208632B2 (en) 2016-04-26 2021-12-28 R.P. Scherer Technologies, Llc Antibody conjugates and methods of making and using the same
HUE057856T2 (hu) 2016-06-01 2022-06-28 Servier Ip Uk Ltd Polialkilén-oxid-aszparagináz készítményei és eljárás ezek elõállítására és alkalmazására
JP2019524651A (ja) 2016-06-08 2019-09-05 アッヴィ・インコーポレイテッド 抗ｃｄ９８抗体及び抗体薬物コンジュゲート
BR112018075649A2 (pt) 2016-06-08 2019-04-09 Abbvie Inc. anticorpos anti-b7-h3 e conjugados de fármaco de anticorpo
LT3458479T (lt) 2016-06-08 2021-02-25 Abbvie Inc. Anti-b7-h3 antikūnai ir antikūnų vaisto konjugatai
CN109563167A (zh) 2016-06-08 2019-04-02 艾伯维公司 抗b7-h3抗体和抗体药物偶联物
US20200147235A1 (en) 2016-06-08 2020-05-14 Abbvie Inc. Anti-cd98 antibodies and antibody drug conjugates
CA3049183A1 (en) 2017-01-05 2018-07-12 Ruey-Kuen HSIEH Treatment of pancreatic cancer
JP7280827B2 (ja) 2017-01-18 2023-05-24 エクスマ バイオテック コーポレイション Ａｘｌまたはｒｏｒ２に対するキメラ抗原受容体およびその使用方法
EP3388082A1 (en) 2017-04-13 2018-10-17 Galera Labs, LLC Combination cancer immunotherapy with pentaaza macrocyclic ring complex
KR20200118823A (ko) 2018-01-31 2020-10-16 갈레라 랩스, 엘엘씨 펜타아자 마크로시클릭 고리 복합체 및 백금-기재 항암제를 사용한 조합 암 요법
AU2019252676A1 (en) 2018-04-11 2020-11-26 Ohio State Innovation Foundation Methods and compositions for sustained release microparticles for ocular drug delivery
WO2020018700A1 (en) 2018-07-18 2020-01-23 Manzanita Pharmaceuticals, Inc. Conjugates for delivering an anti-cancer agent to nerve cells, methods of use and methods of making thereof
JP2022527860A (ja) 2019-04-02 2022-06-06 ケンジョッケティ バイオテクノロジー，インク． 排出ポンプ－癌抗原マルチ特異性抗体ならびにそれに関する組成物、試薬、キットおよび方法
EP4097134A1 (en) 2020-01-29 2022-12-07 Kenjockety Biotechnology, Inc. Anti-mdr1 antibodies and uses thereof
US20230212305A1 (en) 2020-06-04 2023-07-06 Kenjockety Biotechnology, Inc. Anti-abcg2 antibodies and uses thereof
US20230192902A1 (en) 2020-06-04 2023-06-22 Kenjockety Biotechnology, Inc. Abcg2 efflux pump-cancer antigen multi-specific antibodies and compositions, reagents, kits and methods related thereto
JP2023539883A (ja) 2020-09-02 2023-09-20 ケンジョッケティ バイオテクノロジー，インク． 抗ａｂｃｃ１抗体及びその使用
EP4244257A1 (en) 2020-11-13 2023-09-20 Kenjockety Biotechnology, Inc. Anti-mrp4 (encoded by abcc4 gene) antibodies and uses thereof
AR124681A1 (es) 2021-01-20 2023-04-26 Abbvie Inc Conjugados anticuerpo-fármaco anti-egfr
EP4448007A1 (en) 2021-12-13 2024-10-23 William Robert Arathoon Living Trust Dated August 29, 2016 Anti-abcb1 antibodies
WO2023159220A1 (en) 2022-02-18 2023-08-24 Kenjockety Biotechnology, Inc. Anti-cd47 antibodies

Family Cites Families (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US569666A (en) * 1896-10-20 Brake-beam
FR2601676B1 (fr) 1986-07-17 1988-09-23 Rhone Poulenc Sante Procede de preparation du taxol et du desacetyl-10 taxol
FR2629818B1 (fr) * 1988-04-06 1990-11-16 Centre Nat Rech Scient Procede de preparation du taxol
USRE34277E (en) 1988-04-06 1993-06-08 Centre National De La Recherche Scientifique Process for preparing taxol
JPH01309997A (ja) * 1988-06-09 1989-12-14 Kanto Kasei Kogyo Kk 耐食性に優れた銅−ニッケル−クロム光沢電気めっき方法およびそれにより得られためっき皮膜
US4960790A (en) 1989-03-09 1990-10-02 University Of Kansas Derivatives of taxol, pharmaceutical compositions thereof and methods for the preparation thereof
US5175315A (en) * 1989-05-31 1992-12-29 Florida State University Method for preparation of taxol using β-lactam
US5136060A (en) 1989-11-14 1992-08-04 Florida State University Method for preparation of taxol using an oxazinone
FR2678930B1 (fr) * 1991-07-10 1995-01-13 Rhone Poulenc Rorer Sa Procede de preparation de derives de la baccatine iii et de la desacetyl-10 baccatine iii.
US5714513A (en) 1991-09-23 1998-02-03 Florida State University C10 taxane derivatives and pharmaceutical compositions
US5430160A (en) 1991-09-23 1995-07-04 Florida State University Preparation of substituted isoserine esters using β-lactams and metal or ammonium alkoxides
US5229526A (en) * 1991-09-23 1993-07-20 Florida State University Metal alkoxides
US5399726A (en) 1993-01-29 1995-03-21 Florida State University Process for the preparation of baccatin III analogs bearing new C2 and C4 functional groups
US5284864A (en) 1991-09-23 1994-02-08 Florida State University Butenyl substituted taxanes and pharmaceutical compositions containing them
US5990325A (en) 1993-03-05 1999-11-23 Florida State University Process for the preparation of 9-desoxotaxol, 9-desoxobaccatin III and analogs thereof
US5489601A (en) 1991-09-23 1996-02-06 Florida State University Taxanes having a pyridyl substituted side-chain and pharmaceutical compositions containing them
US5654447A (en) 1991-09-23 1997-08-05 Florida State University Process for the preparation of 10-desacetoxybaccatin III
SG46582A1 (en) 1991-09-23 1998-02-20 Univ Florida State 10-Desacetoxytaxol derivatives
FR2687145B1 (fr) 1992-02-07 1994-03-25 Rhone Poulenc Rorer Sa Nouveaux anhydrides d'acides, leur preparation et leur emplot et
US5200534A (en) 1992-03-13 1993-04-06 University Of Florida Process for the preparation of taxol and 10-deacetyltaxol
US5416225A (en) 1992-03-30 1995-05-16 Sloan-Kettering Institute For Cancer Research Total synthesis of taxol
US5254703A (en) 1992-04-06 1993-10-19 Florida State University Semi-synthesis of taxane derivatives using metal alkoxides and oxazinones
US5440056A (en) 1992-04-17 1995-08-08 Abbott Laboratories 9-deoxotaxane compounds
WO1993021173A1 (en) 1992-04-17 1993-10-28 Abbott Laboratories Taxol derivatives
US5269442A (en) * 1992-05-22 1993-12-14 The Cornelius Company Nozzle for a beverage dispensing valve
US5470866A (en) 1992-08-18 1995-11-28 Virginia Polytechnic Institute And State University Method for the conversion of cephalomannine to taxol and for the preparation of n-acyl analogs of taxol
WO1994005282A1 (en) 1992-09-04 1994-03-17 The Scripps Research Institute Water soluble taxol derivatives
US5478854A (en) 1992-10-01 1995-12-26 Bristol-Myers Squibb Company Deoxy taxols
FR2696460B1 (fr) 1992-10-05 1994-11-25 Rhone Poulenc Rorer Sa Procédé de préparation de dérivés du taxane.
FR2696458B1 (fr) 1992-10-05 1994-11-10 Rhone Poulenc Rorer Sa Procédé de préparation de dérivés du taxane.
US5412116A (en) 1992-11-06 1995-05-02 Hauser Chemical Research, Inc. Oxidation of glycoside substituted taxanes to taxol or taxol precursors and new taxane compounds formed as intermediates
FR2698363B1 (fr) 1992-11-23 1994-12-30 Rhone Poulenc Rorer Sa Nouveaux dérivés du taxane, leur préparation et les compositions qui les contiennent.
US5380751A (en) 1992-12-04 1995-01-10 Bristol-Myers Squibb Company 6,7-modified paclitaxels
FR2698871B1 (fr) 1992-12-09 1995-02-24 Rhone Poulenc Rorer Sa Nouveau taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent.
US5646176A (en) 1992-12-24 1997-07-08 Bristol-Myers Squibb Company Phosphonooxymethyl ethers of taxane derivatives
US5948919A (en) * 1993-02-05 1999-09-07 Napro Biotherapeutics, Inc. Paclitaxel synthesis from precursor compounds and methods of producing the same
FR2702212B1 (fr) 1993-03-02 1995-04-07 Rhone Poulenc Rorer Sa Nouveaux taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent.
US5547981A (en) 1993-03-09 1996-08-20 Enzon, Inc. Taxol-7-carbazates
US5703247A (en) 1993-03-11 1997-12-30 Virginia Tech Intellectual Properties, Inc. 2-Debenzoyl-2-acyl taxol derivatives and methods for making same
US5475011A (en) 1993-03-26 1995-12-12 The Research Foundation Of State University Of New York Anti-tumor compounds, pharmaceutical compositions, methods for preparation thereof and for treatment
US5336684A (en) 1993-04-26 1994-08-09 Hauser Chemical Research, Inc. Oxidation products of cephalomannine
IL109926A (en) * 1993-06-15 2000-02-29 Bristol Myers Squibb Co Methods for the preparation of taxanes and microorganisms and enzymes utilized therein
US5405972A (en) 1993-07-20 1995-04-11 Florida State University Synthetic process for the preparation of taxol and other tricyclic and tetracyclic taxanes
FR2718137B1 (fr) 1994-04-05 1996-04-26 Rhone Poulenc Rorer Sa Procédé de préparation de trialcoylsilyl-7 baccatine III.
US6100411A (en) * 1994-10-28 2000-08-08 The Research Foundation Of State University Of New York Taxoid anti-tumor agents and pharmaceutical compositions thereof
EP0788493A1 (en) * 1994-10-28 1997-08-13 The Research Foundation Of State University Of New York Taxoid derivatives, their preparation and their use as antitumor agents
US5489589A (en) 1994-12-07 1996-02-06 Bristol-Myers Squibb Company Amino acid derivatives of paclitaxel
JPH08253465A (ja) * 1995-03-17 1996-10-01 Dai Ichi Seiyaku Co Ltd 四環性化合物
US5847170A (en) * 1995-03-27 1998-12-08 Rhone-Poulenc Rorer, S.A. Taxoids, their preparation and pharmaceutical compositions containing them
MA23823A1 (fr) * 1995-03-27 1996-10-01 Aventis Pharma Sa Nouveaux taxoides, leur preparation et les compositions qui les contiennent
US5780653A (en) 1995-06-07 1998-07-14 Vivorx Pharmaceuticals, Inc. Nitrophenyl, 10-deacetylated substituted taxol derivatives as dual functional cytotoxic/radiosensitizers
US5760251A (en) 1995-08-11 1998-06-02 Sepracor, Inc. Taxol process and compounds
FR2743074B1 (fr) * 1995-12-27 1998-03-27 Seripharm Procede de protection selective des derives de la baccatine et son utilisation dans la synthese des taxanes
US5688977A (en) 1996-02-29 1997-11-18 Napro Biotherapeutics, Inc. Method for docetaxel synthesis
JP4172726B2 (ja) * 1996-05-22 2008-10-29 ルイトポルド・ファーマシューティカルズ・インコーポレーテッド シス―ドコサヘキサエン酸とドセタキセルとの共有複合体を含有する製剤
US5773461A (en) 1996-06-06 1998-06-30 Bristol-Myers Squibb Company 7-deoxy-6-substituted paclitaxels
FR2750989B1 (fr) 1996-07-09 1998-09-25 Rhone Poulenc Rorer Sa Procede de monoacylation d'hydroxy taxanes
US5750736A (en) 1996-07-11 1998-05-12 Napro Biotherapeutics, Inc. Method for acylating 10-deacetylbaccatin III selectively at the c-10 position
US5811452A (en) 1997-01-08 1998-09-22 The Research Foundation Of State University Of New York Taxoid reversal agents for drug-resistance in cancer chemotherapy and pharmaceutical compositions thereof
US6017935A (en) * 1997-04-24 2000-01-25 Bristol-Myers Squibb Company 7-sulfur substituted paclitaxels
ATE252569T1 (de) 1997-05-02 2003-11-15 Pharmachemie Bv Verfahren zur herstellung von baccatin iii und seiner derivate ausgehend von 10-deacetylbaccatin iii.
US7288665B1 (en) * 1997-08-18 2007-10-30 Florida State University Process for selective derivatization of taxanes
US5914411A (en) 1998-01-21 1999-06-22 Napro Biotherapeutics, Inc. Alternate method for acylating 10-deacetylbaccatin III selectively at the C-10 position

Also Published As

Publication number Publication date
AU744987B2 (en) 2002-03-07
PT956284E (pt) 2006-12-29
AU9021198A (en) 1999-03-08
US7288665B1 (en) 2007-10-30
NO20054513L (no) 1999-06-18
CZ296580B6 (cs) 2006-04-12
ID21654A (id) 1999-07-08
CY1105399T1 (el) 2010-04-28
ATE326455T1 (de) 2006-06-15
PL332723A1 (en) 1999-10-11
PL193674B1 (pl) 2007-03-30
CN1205196C (zh) 2005-06-08
IL184320A0 (en) 2007-10-31
ES2274579T3 (es) 2007-05-16
ES2286073T3 (es) 2007-12-01
IL184321A0 (en) 2007-10-31
EP1170293A2 (en) 2002-01-09
EP1170292B1 (en) 2007-04-25
DE69834584D1 (de) 2006-06-22
HUP0300425A3 (en) 2005-12-28
KR20000068782A (ko) 2000-11-25
DK1170292T3 (da) 2007-08-27
DK0956284T3 (da) 2007-02-12
US6191287B1 (en) 2001-02-20
EP0956284A4 (en) 2001-12-05
ZA987394B (en) 1999-05-14
CA2268662A1 (en) 1999-02-25
DE69837684D1 (de) 2007-06-06
KR100596989B1 (ko) 2006-07-07
PT1170292E (pt) 2007-05-31
NO325139B1 (no) 2008-02-11
DE69837684T2 (de) 2007-09-06
EP0956284A1 (en) 1999-11-17
PL201641B1 (pl) 2009-04-30
EP1170292A3 (en) 2002-04-03
US6706896B1 (en) 2004-03-16
EP1170292A2 (en) 2002-01-09
EP1193262A1 (en) 2002-04-03
EP1170293A3 (en) 2002-04-03
CN1239476A (zh) 1999-12-22
EP1170293B1 (en) 2006-05-17
DK1170293T3 (da) 2006-09-11
ATE360624T1 (de) 2007-05-15
SG97986A1 (en) 2003-08-20
NO991838D0 (no) 1999-04-16
EP0956284B1 (en) 2006-10-04
US6291691B1 (en) 2001-09-18
US20050272944A1 (en) 2005-12-08
NO991838L (no) 1999-06-18
CZ133299A3 (cs) 1999-11-17
DE69836072T2 (de) 2007-01-11
DE69834584T2 (de) 2006-11-23
CN100351246C (zh) 2007-11-28
ES2259646T3 (es) 2006-10-16
NO20054512L (no) 1999-06-18
PT1170293E (pt) 2006-07-31
NZ335156A (en) 2001-10-26
ATE341540T1 (de) 2006-10-15
DE69836072D1 (de) 2006-11-16
CN1690053A (zh) 2005-11-02
HUP0300425A2 (hu) 2003-09-29
WO1999009021A1 (en) 1999-02-25
EP1795528A1 (en) 2007-06-13
CA2597799A1 (en) 1999-02-25
CN1974563A (zh) 2007-06-06
EP1671960A2 (en) 2006-06-21
IL129386A0 (en) 2000-02-17
RU2225402C2 (ru) 2004-03-10
BR9806145A (pt) 2000-01-18
JP2001504864A (ja) 2001-04-10

Similar Documents

Publication Publication Date Title
NO20054514L (no) Taksanderivater
TW260673B (no)
SG80525A1 (en) Hindered esters of rapamycin
CA2203942A1 (en) A pyrrolidylthiocarbapenem derivative
NO944691D0 (no) Fremgangsmåte for fremstilling av N- karboksyalkyl-1,4,7,10-tetraazasyklododekan og N- yalkyl-tri-N-karboksyalkyl-1,4,8,11-tetraazasyklotradekanderivater og deres metallkomplekser
DK0655065T3 (no)
ES8507536A1 (es) Un procedimiento para la preparacion de estimulantes cardiacos de quinazolinas.
NO304951B1 (no) Aziridinoantracyklinderivater
IE781193L (en) Nitroso-ureas
JPS5424356A (en) Nonvibratory heat shield
TW372965B (en) Stereoselective process for producing dihydro-2,3-benzodiazepine derivatives
ES2188515T3 (es) Derivados de 22r-hidroxicolesta-8,14-dieno con actividad inhibidora de la meiosis.
RO85226A (ro) Procedeu si instalatie pentru recuperarea energiei gazelor de furnal
UA41890C2 (uk) Спосіб одержання похідних 2-перфторалкіл-3-оксазолін-5-ону (варіанти), перфторалканоїламінонітрильні проміжні сполуки
WO2001012642A3 (de) Nucleosidderivate und verfahren zu deren herstellung
ES469896A1 (es) Procedimiento para la obtencion de derivados de la hidroxi-4tiazolinationa-2
CA2122897A1 (en) Novel pharmaceutically active flavilium compounds
MY106564A (en) Sulfur-substituted mevinic acid derivatives.
ES8404996A1 (es) Un procedimiento para preparar 1-hidroxietil-1h-tetrazol-5-tiolopcionalmente protegido.
EP0654269A4 (en) MEDICAL COMPOSITION FOR INHIBITING CANCER METASAS IN LIVER AND MEDICAL COMPOSITION FOR TREATING THE HEPATOMA.
EP0733630A4 (en) NUCLEOSIDE DERIVATIVES
JPS5242888A (en) Preparation of quinazoline derivatives
GB1170565A (en) Uracil Derivatives
ES2185360T3 (es) Derivados de 22s-hidroxicolesta-8,14-dieno con actividad reguladora de la meiosis.
CA2254506A1 (en) Piperidine derivatives and process for their production